Patients who administer regular injections to manage diabetes should be encouraged to follow best practice

With rising numbers of patients with type 2 diabetes being prescribed insulin and the growing use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), primary care nurses are increasingly managing injectable treatments as part of diabetes care. GLP-1 RAs and insulin for type 2 diabetes usually come as disposable pre-filled pen injectors designed to be self-administered either once or twice a day, or weekly.